• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对使用不同表面活性剂制备的与纤溶酶原(PLG)微粒相关的模型抗原的免疫反应。

The immune response to a model antigen associated with PLG microparticles prepared using different surfactants.

作者信息

Rafati H, Lavelle E C, Coombes A G, Stolnik S, Holland J, Davis S S

机构信息

Department of Pharmaceutical Sciences, University of Nottingham, UK.

出版信息

Vaccine. 1997 Dec;15(17-18):1888-97. doi: 10.1016/s0264-410x(97)00134-5.

DOI:10.1016/s0264-410x(97)00134-5
PMID:9413098
Abstract

The effect of different surfactants on the surface characteristics of poly(D,L-lactideco-glycolide) microparticles prepared by the emulsification/solvent evaporation technique was investigated and the immune response to a protein antigen (OVA) associated with these microparticles was measured. Three surfactants--polyvinyl alcohol (PVA, a conventional stabilizer of PLG microparticles), the non-ionic surfactant, poly(oxyethylene glycerol mono-oleate) [Tagat] and Bile salts (a natural emulsifer)--were used to produce OVA-loaded PLG microparticles. Antigen was detected at the surface of all three types of OVA-loaded microparticles, in amounts in excess of 40% of the total protein load. The levels of specific serum IgG antibody elicited to OVA were significantly higher (P < 0.05) after a single subcutaneous administration of antigen associated with the Bile salts and Tagat formulations compared to the PVA formulation. A strong correlation was revealed between the levels of antibody measured and the magnitude of negative surface charge of the particulate carrier. The pattern of the IgG antibody response to OVA was similar in all three cases, indicating that the degradation rate of the PLG polymer determined the duration of the response. The results demonstrate the potential of using different surfactants to produce PLG microparticles with increased adjuvant activity.

摘要

研究了不同表面活性剂对通过乳化/溶剂蒸发技术制备的聚(D,L-丙交酯-乙交酯)微粒表面特性的影响,并测定了与这些微粒相关的蛋白质抗原(OVA)的免疫反应。使用三种表面活性剂——聚乙烯醇(PVA,PLG微粒的传统稳定剂)、非离子表面活性剂聚(氧乙烯甘油单油酸酯)[Tagat]和胆盐(一种天然乳化剂)——来制备负载OVA的PLG微粒。在所有三种负载OVA的微粒表面均检测到抗原,其含量超过总蛋白负载量的40%。与PVA制剂相比,单次皮下注射与胆盐和Tagat制剂相关的抗原后,引发的针对OVA的特异性血清IgG抗体水平显著更高(P<0.05)。所测抗体水平与颗粒载体负表面电荷的大小之间存在很强的相关性。在所有三种情况下,对OVA的IgG抗体反应模式相似,表明PLG聚合物的降解速率决定了反应的持续时间。结果证明了使用不同表面活性剂制备具有增强佐剂活性的PLG微粒的潜力。

相似文献

1
The immune response to a model antigen associated with PLG microparticles prepared using different surfactants.对使用不同表面活性剂制备的与纤溶酶原(PLG)微粒相关的模型抗原的免疫反应。
Vaccine. 1997 Dec;15(17-18):1888-97. doi: 10.1016/s0264-410x(97)00134-5.
2
The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.基于丙交酯聚合物和聚乙二醇共混物的可生物降解微粒中包裹的蛋白质抗原的稳定性和免疫原性。
Vaccine. 1999 Feb 12;17(6):512-29. doi: 10.1016/s0264-410x(98)00229-1.
3
PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems.使用肠溶包衣聚合物稳定化的纤溶酶原微粒作为口服疫苗递送系统。
Vaccine. 1999 Jul 16;17(22):2927-38. doi: 10.1016/s0264-410x(99)00140-1.
4
Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen.单剂量、基于聚合物微粒的疫苗:制剂条件对蛋白质抗原免疫反应的强度和持续时间的影响。
Vaccine. 1996 Oct;14(15):1429-38. doi: 10.1016/s0264-410x(96)00077-1.
5
Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles.用包裹在可生物降解微粒中的卵清蛋白对小鼠进行皮下免疫后的长期抗体反应。
Vaccine. 1993;11(9):965-9. doi: 10.1016/0264-410x(93)90387-d.
6
Formulation and optimization of nonionic surfactants emulsified nimesulide-loaded PLGA-based nanoparticles by design of experiments.通过实验设计制备和优化非离子表面活性剂乳化的尼美舒利载 PLGA 纳米粒。
AAPS PharmSciTech. 2014 Feb;15(1):161-76. doi: 10.1208/s12249-013-0048-9. Epub 2013 Nov 13.
7
A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2.将可生物降解微粒与MF59作为单纯疱疹病毒2型重组gD的全身佐剂的比较。
Vaccine. 1998 Nov;16(19):1822-7. doi: 10.1016/s0264-410x(98)00179-0.
8
The distribution of protein associated with poly(DL-lactide co-glycolide) microparticles and its degradation in simulated body fluids.聚(DL-丙交酯乙交酯)微粒相关蛋白质的分布及其在模拟体液中的降解
J Control Release. 1998 Jan 2;50(1-3):237-46. doi: 10.1016/s0168-3659(97)00145-4.
9
Improving protein delivery from microparticles using blends of poly(DL lactide co-glycolide) and poly(ethylene oxide)-poly(propylene oxide) copolymers.使用聚(DL-丙交酯乙交酯)和聚(环氧乙烷-环氧丙烷)共聚物的混合物改善从微粒的蛋白质递送。
Pharm Res. 1996 Nov;13(11):1693-8. doi: 10.1023/a:1016496824839.
10
Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly(D,L-lactide-co-glycolide) microparticles.用包裹于聚(D,L-丙交酯-共-乙交酯)微粒中的幽门螺杆菌裂解物进行口服免疫诱导黏膜和全身免疫反应。
Vaccine. 1999 Feb 12;17(6):607-16. doi: 10.1016/s0264-410x(98)00241-2.

引用本文的文献

1
Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery.Claudin 4 靶向蛋白被包裹在 PLGA 纳米粒中,可介导 M 细胞靶向递药。
J Control Release. 2010 Mar 3;142(2):196-205. doi: 10.1016/j.jconrel.2009.10.033. Epub 2009 Nov 5.
2
Novel bioresorbable and bioeliminable surfactants for microsphere preparation.用于制备微球的新型可生物吸收和生物消除的表面活性剂。
Pharm Res. 1999 Jan;16(1):148-54. doi: 10.1023/a:1018895417915.